Analyst firms · Goldman Sachs · ALHC
Goldman Sachs ALHC price target and rating history
Alignment Healthcare Inc. (ALHC) · Health Care
Goldman Sachs rates Alignment Healthcare Inc. (ALHC) Buy with a $21 price target, as of its latest action on Oct 14, 2025. It has published 3 rating actions on ALHC since December 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $21
- Median target, all firms
- Too few
- Actions on ALHC
- 3
Goldman Sachs price target on ALHC
Every Goldman Sachs rating on ALHC
- Oct 14, 2025
- Mar 7, 2022
- Dec 14, 2021
How other firms rate ALHC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| KeyBanc Capital Markets | Sector Weight | Oct 30, 2026 | |
| Needham | Hold | Oct 28, 2026 | |
| William Blair | Mkt Perform | Oct 9, 2026 | |
| Raymond James | Outperform | $19 | Aug 3, 2026 |
| Wolfe Research | Outperform | $24 | Apr 17, 2026 |
Questions about Goldman Sachs and ALHC
- What is Goldman Sachs's price target for ALHC?
- Goldman Sachs's latest stated price target for Alignment Healthcare Inc. (ALHC) is $21, from its action on Oct 14, 2025.
- What is Goldman Sachs's rating on ALHC?
- Goldman Sachs rates ALHC Buy, a bullish rating, as of Oct 14, 2025.
- When did Goldman Sachs last change its view on ALHC?
- On Oct 14, 2025, Goldman Sachs starts coverage at Buy, price target $21.
More ALHC rating histories
All Goldman Sachs ratingsALHC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.